Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide
Abstract Chidamide is the first oral subtype-selective histone deacetylase inhibitor approved in China for the treatment of relapsed and refractory peripheral T cell lymphoma. Due to the existence of isomers, many articles or patents have mistaken its structure. Herein we explored the synthesis of t...
Saved in:
Main Authors: | Bo Han (Author), Xin-Yan Peng (Author), Yan-Qing Gong (Author), Jia-Liang Zhong (Author), Qing-Wei Zhang (Author) |
---|---|
Format: | Book |
Published: |
Georg Thieme Verlag KG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020) -
Design, Synthesis and Cytotoxicity Study of Primary Amides as Histone Deacetylase Inhibitors
by: Duraid Al-Amily, et al.
Published: (2019) -
Design, synthesis and biological evaluation of novel histone deacetylase inhibitors based on virtual screening
by: Hui Lu, et al.
Published: (2011) -
Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010) -
Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021)